Velico Medical receives $18.9M BARDA funding for spray dried plasma development

BARDA exercised its third option under a contract with Velico Medical, providing an additional $18.9 million for development of spray dried plasma technology, raising total commitment to $46.5 million.

“BARDA has exercised its third option under a contract with Velico® which extends through November 2019 and provides for up to approximately $18.9 million of additional funding raising the total value of its commitment to Velico® to $46.5 million.”veli.co

• 1 source
• veli.coVelico® Medical Announces a Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma - Velico®idea-developerSep 26, 2017

Summarized from public sources; check the original articles before acting on it.